Market Analysis and Price Projections for the Drug NDC: 68382-0750
Introduction to NDC and Drug Identification
The National Drug Code (NDC) is a unique, three-segment number used to identify drug products in the United States. For the drug with the NDC 68382-0750, this code breaks down into three parts: the labeler code, the product code, and the package code. The labeler code (68382) is assigned by the FDA and identifies the firm responsible for the drug, such as the manufacturer or distributor. The product code identifies the specific strength, dosage form, and formulation of the drug, while the package code specifies the package size and type[1][5].
Drug Pricing Trends
To analyze the market and price projections for the drug with NDC 68382-0750, it is essential to consider broader trends in the pharmaceutical industry. Over the past few years, prescription drug prices in the U.S. have seen significant increases. For example, between 2017 and 2022, the average price increase for prescription drugs was around 14%[2].
Current Pricing and Historical Data
While specific pricing data for NDC 68382-0750 is not provided in the sources, we can look at similar drugs for context. For instance, the price of sirolimus (another drug with a similar NDC format) has fluctuated over time. As of recent dates, the price per unit for sirolimus 0.5 mg tablets ranged from $2.13 to $2.75 per unit[2].
Market Growth and Projections
The U.S. pharmaceutical market is projected to grow significantly from $846.72 billion in 2022 to $1.28 trillion by 2030, representing a Compound Annual Growth Rate (CAGR) of 5.36%[4]. This growth is driven by several factors, including an increase in pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments.
Impact of Generic Drugs and Biosimilars
The rise of generic drugs and biosimilars is a critical trend affecting the pharmaceutical market. Nearly 37% of life sciences executives view competition from generic drugs and biosimilars as a top trend, which can impact the pricing and market share of branded drugs[3].
Patent Cliff and Exclusivity Loss
The biopharma industry is facing a substantial loss of exclusivity due to expiring patents on high-revenue products, with over $300 billion in sales at risk through 2030. This could lead to increased competition from generics and biosimilars, potentially affecting the pricing strategy for drugs like the one with NDC 68382-0750[3].
Digital Transformation and Innovation
The integration of technologies such as AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations in the pharmaceutical industry. This could lead to more precise treatment options and better patient outcomes, but it also introduces new challenges in terms of pricing and access to these innovative therapies[3].
Pricing and Access Challenges
Pricing and access to drugs remain significant issues for the life sciences industry. Nearly half of the C-suite executives surveyed expect pricing and access to significantly affect their strategies in 2025. This trend highlights the need for pharmaceutical companies to navigate external pressures on pricing and reimbursement effectively[3].
Regulatory Environment
The FDA's National Drug Code Directory plays a crucial role in regulating and tracking drug products, including those with NDCs like 68382-0750. Drug establishments must provide the FDA with a current list of all drugs manufactured, prepared, propagated, compounded, or processed for sale in the U.S.[5].
Price Projections
Given the broader trends and the lack of specific data for NDC 68382-0750, it is challenging to make precise price projections. However, considering the average price increase of 14% over the past few years and the ongoing growth of the pharmaceutical market, it is reasonable to expect that prices for this drug could continue to rise, albeit potentially at a slower rate due to increased competition from generics and biosimilars.
Key Takeaways
- NDC Structure: The NDC 68382-0750 is a unique identifier for a specific drug product, broken down into labeler, product, and package codes.
- Pricing Trends: Prescription drug prices have increased by an average of 14% between 2017 and 2022.
- Market Growth: The U.S. pharmaceutical market is projected to grow to $1.28 trillion by 2030.
- Generic and Biosimilar Impact: Increased competition from generics and biosimilars could affect pricing and market share.
- Digital Transformation: AI and data integration are expected to drive innovations but also introduce new pricing challenges.
- Regulatory Compliance: The FDA's NDC Directory ensures regulatory compliance for drug products.
FAQs
Q: What does the National Drug Code (NDC) represent?
A: The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package details.
Q: How is the NDC structured?
A: The NDC is structured into three segments: the labeler code, the product code, and the package code, totaling 10 digits in configurations like 4-4-2, 5-3-2, or 5-4-1[1].
Q: What are the key drivers of the U.S. pharmaceutical market growth?
A: The growth is driven by an increase in pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[4].
Q: How do generic drugs and biosimilars impact the pharmaceutical market?
A: They increase competition, potentially affecting the pricing and market share of branded drugs, and are viewed as a significant trend by industry executives[3].
Q: What role does AI play in the pharmaceutical industry?
A: AI is emerging as a crucial tool for drug discovery, boosting operational efficiencies and driving breakthrough innovations[4].
Sources
- FDA: National Drug Code Database Background Information
- DrugPatentWatch: Latest pharmaceutical drug prices and trends for NDC 68382-0520
- Deloitte Insights: 2025 life sciences outlook
- GlobeNewswire: US Pharmaceutical Market Review 2020-2023 and Forecast
- FDA: National Drug Code Directory
